T细胞微环境影响和治疗机会:适用于人类丸胚芽细胞瘤
R Islam1,2,3,4, M Figura1, J Heyer1,5
1Institute For Veterinary Anatomy, Histology and Embryology, Justus Liebig University Giessen, Giessen, Germany.
Andrology
|March 3, 2026
概括
丸生殖细胞瘤 (TGCT) 破坏了免疫特权的丸微环境. 在TGCT中了解T细胞动态对于开发有效的免疫疗法和改善患者治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 丸生殖细胞瘤 (TGCT) 是年轻男性中最常见的癌症.
- 人们对丸瘤微环境 (TME) 和其免疫格局的了解很少.
- 哺乳动物的丸是免疫特权的器官,但这种特权在TGCT中被破坏.
研究的目的:
- 审查TGCT的病理生物学,重点关注免疫环境.
- 评估T细胞在TGCT TME中的各种T细胞子集的作用.
- 突出需要更好地了解T细胞动态,以改善免疫疗法.
主要方法:
- 关于TGCT病理生物学和免疫学的综合文献综述.
- 在TME内分析免疫细胞子集,特别是T细胞 (CD4+和CD8+).
- 讨论单细胞转录组学和临床研究的最新进展.
主要成果:
- TGCT 破坏丸免疫特权,改变免疫细胞的组成和功能.
- 不同的CD4+和CD8+T细胞子集在抗瘤免疫,免疫调节和免疫逃避中起着复杂的作用.
- 目前的免疫疗法在TGCT中表现出有限的疗效,这是由于丸独特的免疫环境.
结论:
- 阐明T细胞亚群及其在TGCT TME中的相互作用至关重要.
- 高分辨率的表征是开发新型免疫治疗策略所必需的.
- 更好的理解将提高临床结果,并最大限度地减少TGCT患者的治疗后果.
相关概念视频
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K


